In vitro proliferation and osteogenic differentiation of mesenchymal stem cells on nanoporous alumina

International Journal of Nanomedicine

Volumn 8, Issue , 2013, Pages 2745-2756

  Song, Yuanhui ^a   Ju, Yang ^a   Song, Guanbin ^b   Morita, Yasuyuki ^a  

^a NAGOYA UNIVERSITY   (Japan)

^b CHONGQING UNIVERSITY   (China)

Author keywords

Differentiation; Mesenchymal stem cells; Nanoporous alumina; Proliferation; Tissue engineering

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ALKALINE PHOSPHATASE; ALUMINUM OXIDE; BETA INTEGRIN; BETA INTEGRIN 1; OSTEOCALCIN; UNCLASSIFIED DRUG;

ARTICLE; BONE DEVELOPMENT; BONE MINERALIZATION; CELL ADHESION; CELL ASSAY; CELL CULTURE; CELL DIFFERENTIATION; CELL FUNCTION; CELL GROWTH; CELL INTERACTION; CELL PROLIFERATION; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; MEMBRANE STRUCTURE; MESENCHYMAL STEM CELL; OSTEOBLAST; POROSITY; PROTEIN EXPRESSION; SCANNING ELECTRON MICROSCOPY; TISSUE ENGINEERING;

DIFFERENTIATION; MESENCHYMAL STEM CELLS; NANOPOROUS ALUMINA; PROLIFERATION; TISSUE ENGINEERING;

ALKALINE PHOSPHATASE; ALUMINUM OXIDE; ANTIGENS, CD29; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SHAPE; CELL SURVIVAL; CELLS, CULTURED; HUMANS; MESENCHYMAL STROMAL CELLS; MICROSCOPY, FLUORESCENCE; NANOSTRUCTURES; OSTEOCALCIN; OSTEOGENESIS; POLYMERASE CHAIN REACTION; POROSITY; TISSUE ENGINEERING;

EID: 84880950259     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S44885     Document Type: Article

References (64)

1. Ratner BD, Bryant SJ. Biomaterials: where we have been and where we are going. Annu Rev Biomed Eng. 2004;6:41-75.
2. Wennerberg A, Albrektsson T, Andersson B. An animal study of c.p. titanium screws with different surface topographies. J Mater Sci Mater M. 1995;6:302-309.
3. Li LH, Kong YM, Kim HW, et al. Improved biological performance of Ti implants due to surface modification by micro-arc oxidation. Biomaterials. 2004;25:2867-2875.
4. Lord MS, Foss M, Besenbacher F. Influence of nanoscale surface topography on protein adsorption and cellular response. Nano Today. 2010;5:66-78.
5. Wan Y, Wang Y, Liu Z, et al. Adhesion and proliferation of OCT-1 osteoblast-like cells on micro and nano-scale topography structured poly(L-lactide). Biomaterials. 2005;26:4453-4459.
6. Théry M, Racine V, Pépin A, et al. The extracellular matrix guides the orientation of the cell division axis. Nat Cell Biol. 2005;7:947-953.
7. Wang L, Lei L, Ni XF, Chen Y. Patterning bio-molecules for cell attachment at single cell levels in PDMS microfluidic chips. Microelectron Eng. 2009;86:1462-1464.
8. Tamai N, Myoui A, Tomita T, et al. Novel hydroxyapatite ceramics with an interconnective porous structure exhibit superior osteoconduction in vivo. J Biomed Mater Res. 2002;59:110-117.
9. Hing KA. Bioceramic bone graft substitutes: influence of porosity and chemistry. Int J Appl Ceram Technol. 2005;2:184-199.
10. Karlsson M, Pålsgård E, Wilshaw PR, Di Silvio L. Initial in vitro interaction of osteoblasts with nanoporous alumina. Biomaterials. 2003;24: 3039-3046.
11. Swan EL, Popat KC, Desai TA. Peptide immobilized nanoporous alumina membranes for enhanced osteoblast adhesion. Biomaterials. 2005;26:1969-1976.
12. Hoess A, Teuscher N, Thormann A, Aurich H, Heilmann A. Cultivation of hepatoma cell line HepG2 on nanoporous aluminum oxide membranes. Acta Biomater. 2007;3:43-50.
13. Marinucci L, Balloni S, Becchetti E, et al. Effects of hydroxyapatite and biostite on osteogenic induction of hMSC. Ann Biomed Eng. 2010;38: 640-648.
14. Zannettino A, Paton S, Arthur A, et al. Multipotential human adiposederived stromal stem cells exhibit a perivascular phenotype in vitro and in vivo. J Cell Physiol. 2008;214:413-421.
15. Engler AJ, Sen S, Sweeney HL, Discher DE. Matrix elasticity directs stem cell lineage specification. Cell. 2006;126:677-689.
16. Morganstein DL, Wu P, Mane MR, Fisk NM, White R, Parker MG. Human fetal mesenchymal stem cells differentiate into brown and white adipocytes: a role for ERRα in human UCP1 expression. Cell Res. 2010;20:434-444.
17. Xu B, Song G, Ju Y. Effect of focal adhesion kinase signaling on the regulation of alignment and tenogenic differentiation of human mesenchymal stem cells by mechanical stretch. Connect Tissue Res. 2011;52: 373-379.
18. Park J, Bauer S, Schlegel KA, Neukam FW, von der Mark K, Schmuki P. TiO2 nanotube surfaces: 15 nm-an optimal length scale of surface topography for cell adhesion and differentiation. Small. 2009;5:666-671.
19. Gotoh Y, Hiraiwa K, Nagayama M. In vitro mineralization of osteoblastic cells derived from human bone. Bone Miner. 1990;8:239-250.
20. Nakamura A, Dohi Y, Akahane M, et al. Osteocalcin secretion as an early marker of in vitro osteogenic differentiation of rat mesenchymal stem cells. Tissue Eng Part C Methods. 2009;15:169-180.
21. Dalby MJ, Di Silvio L, Harper EJ, Bonfield W. In vitro adhesion and biocompatibility of osteoblast-like cells to poly(methylmethacrylate) and poly(ethylmethacrylate) bone cements. J Mater Sci Mater Med. 2002;13:311-314.
22. Popat KC, Leary Swan EE, Mukhatyar V, et al. Influence of nanoporous alumina membranes on long-term osteoblast response. Biomaterials. 2005;26:4516-4522.
23. Chung SH, Son SJ, Min J. The nanostructure effect on the adhesion and growth rates of epithelial cells with well-defined nanoporous alumina substrate. Nanotechnology. 2010;21:125104-125110.
24. Hu J, Tian JH, Shi J, et al. Cell culture on AAO nanoporous substrates with and without geometry constraints. Microelectron Eng. 2011;88: 1714-1717.
25. Park J, Bauer S, von der Mark K, Schmuki P. Nanosize and vitality: TiO2 nanotube diameter directs cell fate. Nano Lett. 2007;7:1686-1691.
26. Oh S, Brammer KS, Li YS, et al. Stem cell fate dictated solely by altered nanotube dimension. Proc Natl Acad Sci U S A. 2009;106: 2130-2135.
27. Burridge K, Chrzanowska-Wodnicka M. Focal adhesions, contractility, and signaling. Annu Rev Cell Dev Biol. 1996;12:463-518.
28. Giancotti FG. A structural view of integrin activation and signaling. Dev Cell. 2003;4:149-151.
29. Schlaepfer DD, Hauck CR, Sieg DJ. Signaling through focal adhesion kinase. Prog Biophys Mol Biol. 1999;71:435-478.
30. Mitra SK, Hanson DA, Schlaepfer DD. Focal adhesion kinase: in command and control of cell motility. Nat Rev Mol Cell Biol. 2005;6: 56-68.
31. Calderwood DA. Integrin activation. J Cell Sci. 2004;117:657-666.
32. Rowland TJ, Miller LM, Blaschke AJ, et al. Roles of integrins in human induced pluripotent stem cell growth on Matrigel and vitronectin. Stem Cells Dev. 2010;19:1231-1240.
33. Abraham S, Kogata N, Fässler R, Adams RH. Integrin beta1 subunit controls mural cell adhesion, spreading, and blood vessel wall stability. Circ Res. 2008;102:562-570.
34. Cavalcanti-Adam EA, Volberg T, Micoulet A, Kessler H, Geiger B, Spatz JP. Cell spreading and focal adhesion dynamics are regulated by spacing of integrin ligands. Biophys J. 2007;92:2964-2974.
35. Xiong JP, Stehle T, Diefenbach B, et al. Crystal structure of the extracellular segment of integrin alpha Vbeta3. Science. 2001;294:339-345.
36. Erb EM, Tangemann K, Bohrmann B, Müller B, Engel J. Integrin alphaIIb beta3 reconstituted into lipid bilayers is nonclustered in its activated state but clusters after fibrinogen binding. Biochemistry. 1997;36:7395-7402.
37. DeMali KA, Wennerberg K, Burridge K. Integrin signaling to the actin cytoskeleton. Curr Opin Cell Biol. 2003;15:572-582.
38. Shibue T, Weinberg RA. Integrin beta1-focal adhesion kinase signaling directs the proliferation of metastatic cancer cells disseminated in the lungs. Proc Natl Acad Sci U S A. 2009;106:10290-10295.
39. Arnold M, Cavalcanti-Adam EA, Glass R, et al. Activation of integrin function by nanopatterned adhesive interfaces. Chemphyschem. 2004;5: 383-388.
40. Dolatshahi-Pirouz A, Jensen TH, Kolind K, et al. Cell shape and spreading of stromal (mesenchymal) stem cells cultured on fibronectin coated gold and hydroxyapatite surfaces. Colloids Surf B Biointerfaces. 2011;84:18-25.
41. García AJ, Vega MD, Boettiger D. Modulation of cell proliferation and differentiation through substrate-dependent changes in fibronectin conformation. Mol Biol Cell. 1999;10:785-798.
42. Gao L, McBeath R, Chen CS. Stem cell shape regulates a chondrogenic versus myogenic fate through Rac1 and N-cadherin. Stem Cells. 2010;28:564-572.
43. Folkman J, Moscona A. Role of cell shape in growth control. Nature. 1978;273:345-349.
44. Haeuptle MT, Suard YL, Bogenmann E, Reggio H, Racine L, Kraehenbuhl JP. Effect of cell shape change on the function and differentiation of rabbit mammary cells in culture. J Cell Biol. 1983;96: 1425-1434.
45. McBeath R, Pirone DM, Nelson CM, Bhadriraju K, Chen CS. Cell shape, cytoskeletal tension, and RhoA regulate stem cell lineage commitment. Dev Cell. 2004;6:483-495.
46. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284:143-147.
47. Jaiswal N, Haynesworth SE, Caplan AI, Bruder SP. Osteogenic differentiation of purified, culture expanded human mesenchymal stem cells in vitro. J Cell Biochem. 1997;64:295-312.
48. Lieberman JR, Daluiski A, Einhorn TA. The role of growth factors in the repair of bone. Biology and clinical applications. J Bone Joint Surg Am. 2002;84:1032-1044.
49. Koch H, Jadlowiec JA, Campbell PG. Insulin-like growth factor-I induces early osteoblast gene expression in human mesenchymal stem cells. Stem Cells Dev. 2005;14:621-631.
50. Lavenus S, Berreur M, Trichet V, Pilet P, Louarn G, Layrolle P. Adhesion and osteogenic differentiation of human mesenchymal stem cells on titanium nanopores. Eur Cell Mater. 2011;22:84-96.
51. Zouani OF, Chanseau C, Brouillaud B, et al. Altered nanofeature size dictates stem cell differentiation. J Cell Sci. 2012;125:1217-1224.
52. Dalby MJ, Gadegaard N, Tare R, et al. The control of human mesenchymal cell differentiation using nanoscale symmetry and disorder. Nat Mater. 2007;6:997-1003.
53. Owen TA, Aronow M, Shalhoub V, et al. Progressive development of the rat osteoblast phenotype in vitro: reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J Cell Physiol. 1990;143:420-430.
54. Sjöström T, Dalby MJ, Hart A, et al. Fabrication of pillar-like titania nanostructures on titanium and their interactions with human skeletal stem cells. Acta Biomater. 2009;5:1433-1441.
55. George J, Kuboki Y, Miyata T. Differentiation of mesenchymal stem cells into osteoblasts on honeycomb collagen scaffolds. Biotechnol Bioeng. 2006;95:404-411.
56. Zhang H, Migneco F, Lin CY, et al. Chemically-conjugated bone morphogenetic protein-2 on three-dimensional polycaprolactone scaffolds stimulates osteogenic activity in bone marrow stromal cells. Tissue Eng Part A. 2010;16:3441-3448.
57. Pungchanchaikul P, Bloch-Zupan A, Ferretti P. Delayed osteoprogenitor differentiation in cleft-palate models. Cells Tissues Organs. 2010;192: 283-291.
58. Lee JS, Lee JM, Im GI. Electroporation-mediated transfer of Runx2 and Osterix genes to enhance osteogenesis of adipose stem cells. Biomaterials. 2011;32:760-768.
59. de Crombrugghe B, Lefebvre V, Nakashima K. Regulatory mechanisms in the pathways of cartilage and bone formation. Curr Opin Cell Biol. 2001;13:721-727.
60. Yoshida CA, Furuichi T, Fujita T, et al. Core-binding factor beta interacts with Runx2 and is required for skeletal development. Nat Genet. 2002;32:633-638.
61. Ducy P, Karsenty G. Two distinct osteoblast-specific cisacting elements control expression of a mouse osteocalcin gene. Mol Cell Biol. 1995;15:1858-1869.
62. Zhang S, Xiao Z, Luo J, He N, Mahlios J, Quarles LD. Dosedependent effects of Runx2 on bone development. J Bone Miner Res. 2009;24:1889-1904.
63. Jang WG, Kim EJ, Kim DK, et al. BMP2 protein regulates osteocalcin expression via Runx2-mediated Atf6 gene transcription. J Biol Chem. 2012;287:905-915.
64. Wang W, Zhao L, Wu K, et al. The role of integrin-linked kinase/β catenin pathway in the enhanced MG63 differentiation by micro/ nano-textured topography. Biomaterials. 2013;34:631-640.